A study comprehensively evaluated occurrence patterns of immune-related adverse events, including those affecting single organs and multiple organs. Researchers found that most events tend to co-occur and identified seven patient clusters with different development patterns, which were associated with improved or worsened survival outc...
SourceMassachusetts General Hospital·JournalThe Lancet Oncology·TypeData/statistical analysis·DateJul 16, 2024
Researchers at Memorial Sloan Kettering Cancer Center found that the spatial arrangement of three immune cells - dendritic cell, cytotoxic T cell, and helper T cell - is crucial for effective killing of cancer cells. This discovery has immediate therapeutic implications for immunotherapy treatments.
SourceMemorial Sloan Kettering Cancer Center·JournalCancer Cell·TypeExperimental study·DateJul 15, 2024
A team of researchers has discovered a mechanism by which the liver's immune cells are suppressed in chronic hepatitis B, leading to organ damage. The 'sleep timer' function allows immune cells to weaken their activity over time, preventing them from proliferating excessively and causing further damage.
SourceTechnical University of Munich (TUM)·JournalNature·TypeExperimental study·DateJul 10, 2024
Apple Watch Series 11 (GPS, 46mm)
Apple Watch Series 11 (GPS, 46mm) tracks health metrics and safety alerts during long observing sessions, fieldwork, and remote expeditions.
Researchers discovered that dexamethasone works in patients with severe COVID-19 by influencing impaired inflammatory response through specific immune cells. A predictive tool using single-cell analysis can identify early responders to treatment, offering hope for targeted therapy development.
SourceDZNE - German Center for Neurodegenerative Diseases·JournalCell·TypeObservational study·DateJul 3, 2024
The new consensus guidance outlines what NHS services need to offer Palforzia desensitization treatment at scale, regardless of patient location or background. The recommendations aim to equitably provide an actual treatment for peanut allergy, moving beyond avoidance and education.
SourceWiley·JournalClinical & Experimental Allergy·DateJun 26, 2024
A new trial indicates that immunotherapy could successfully treat the most common form of colorectal cancer. The study, published in Nature Medicine, found that botensilimab and balstilimab caused tumours to shrink or remain stable in 61% of patients with microsatellite stable metastatic colorectal cancer.
SourceAnglia Ruskin University·JournalNature Medicine·DateJun 14, 2024
Researchers at Wyss Institute develop subcutaneous scaffolds to restimulate CAR-T cells, increasing therapeutic efficacy in mice with aggressive blood tumors. The biomaterials increase CAR-T cell numbers and steer differentiation into tumor-killing T cells.
SourceWyss Institute for Biologically Inspired Engineering at Harvard·JournalNature Biomedical Engineering·TypeExperimental study·DateJun 12, 2024
Researchers developed a human pancreatic cancer fibrotic barrier model to assess treatment strategies and test efficacy of therapeutic interventions. Inhibition of ROCK2 pathway resulted in reduced ECM remodeling and improved tissue permeability for drugs, highlighting its potential for enhancing drug delivery in PDAC.
SourceOkayama University·JournalJournal of Controlled Release·TypeExperimental study·DateJun 5, 2024
Apple iPhone 17 Pro
Apple iPhone 17 Pro delivers top performance and advanced cameras for field documentation, data collection, and secure research communications.
Researchers identified two groups of follicular helper lymphocytes that produce different types of antibodies in response to virus infections and allergies. This discovery could lead to new treatments for allergy diseases without affecting immune responses to infections.
SourceInstituto de Medicina Molecular·JournalCell Discovery·TypeExperimental study·DateJun 4, 2024
The NADINA trial found that 59% of patients responded well to neoadjuvant immunotherapy before surgery, allowing them to forgo adjuvant treatment. This treatment approach also showed rapid effects, with 95% of patients remaining tumor-free after just six weeks.
SourceNetherlands Cancer Institute·JournalNew England Journal of Medicine·TypeRandomized controlled/clinical trial·DateJun 2, 2024
Researchers at University of Turku have discovered a novel RNA that controls the development and function of regulatory T cells. This finding may enable the development of precision medicine treatments for autoimmune diseases and cancer.
SourceUniversity of Turku·JournalProceedings of the National Academy of Sciences·DateMay 30, 2024
A new type of immunotherapy has been developed to treat bone cancer osteosarcoma, with promising preclinical results in mice. The treatment uses gamma-delta T cells, which are less well-known immune cells that can be engineered to target tumours.
SourceUniversity College London·JournalScience Translational Medicine·TypeExperimental study·DateMay 29, 2024
SAMSUNG T9 Portable SSD 2TB
SAMSUNG T9 Portable SSD 2TB transfers large imagery and model outputs quickly between field laptops, lab workstations, and secure archives.
A new study published in Nature Biomedical Engineering shows that targeted cancer treatment using antibody-displaying extracellular vesicles reduces tumour growth and improves survival in mice. The treatment has the potential to be used against other diseases and cancer types, offering a more effective and fewer side effects compared t...
SourceKarolinska Institutet·JournalNature Biomedical Engineering·TypeExperimental study·DateMay 20, 2024
A Cleveland Clinic-led team of scientists discovered that protein VISTA can directly turn off tumor-fighting T-cells during immunotherapy and resist treatment. The interaction between VISTA and a newly discovered inhibitory receptor LRIG1 suppresses T cell replication, survival, and function.
SourceCleveland Clinic·JournalScience Immunology·DateMay 17, 2024
Researchers found that ARID1A mutation renders tumors sensitive to immunotherapy by triggering an antiviral immune response. This could lead to improved patient outcomes and the development of targeted therapies.
The Ottawa Hospital is receiving a $59 million grant to boost Canada's capacity for life-saving biotherapeutics, including vaccines, gene therapies, and cell therapies. The funding will support the construction and operation of a world-class biomanufacturing facility at its new campus.
Researchers from Wyss Institute and Harvard University developed a biomaterial vaccine that enhances and sustains lymph node expansion, leading to more effective anti-tumor responses. The vaccine formulation, based on microscale mesoporous silica rods, reprograms antigen-presenting cells to orchestrate complex immune responses.
SourceWyss Institute for Biologically Inspired Engineering at Harvard·JournalNature Biomedical Engineering·TypeExperimental study·DateMay 6, 2024
Kestrel 3000 Pocket Weather Meter
Kestrel 3000 Pocket Weather Meter measures wind, temperature, and humidity in real time for site assessments, aviation checks, and safety briefings.
Researchers from Scripps Research have enhanced an existing immunotherapy by removing the sugar coating surrounding solid tumors, allowing T cells to more effectively kill tumor cells. The tweak improves T-cell killing of tumor cells in mouse models, with promising results for treating solid tumors.
SourceScripps Research Institute·JournalNature Biomedical Engineering·DateMay 1, 2024
The McMaster University research team created the first-ever guidelines for preparing families to build their child's tolerance to common food allergens through oral immunotherapy. The guidelines, published in the Journal of Allergy and Clinical Immunology, standardize the preparation process and provide a consent form template.
SourceMcMaster University·JournalJournal of Allergy and Clinical Immunology·DateApr 8, 2024
Researchers have discovered a new immunotherapy approach to overcome resistant leukemia by targeting the mutated TP53 gene. Combining pharmacological therapies with genetically engineered CAR T-cells increases effectiveness against cancer cells, offering promising strategies for patients with resistant disease.
SourceUniversity of Zurich·JournalEMBO Molecular Medicine·TypeExperimental study·DateMar 21, 2024
Researchers have demonstrated that attaching 'empty' backpacks to neutrophils activates them against cancer. The treated neutrophils infused into mice with cancer activated other immune cells and reduced tumor size. This technique is attractive as a 'drug-free' cell therapy for cancer.
SourceWyss Institute for Biologically Inspired Engineering at Harvard·JournalNature Biomedical Engineering·TypeExperimental study·DateMar 19, 2024
Researchers investigated the role of long-lived plasma cells in COVID-19 infection, finding deficient generation of spike-specific antibodies. The study suggests that inadequate long-lived plasma cell production may be responsible for short-lived protective antibody responses to SARS-CoV-2.
SourceUniversity of Maryland School of Medicine·JournalThe Journal of Infectious Diseases·TypeExperimental study·DateMar 18, 2024
AmScope B120C-5M Compound Microscope
AmScope B120C-5M Compound Microscope supports teaching labs and QA checks with LED illumination, mechanical stage, and included 5MP camera.
Researchers have developed a novel immunotheraphy targeting macrophages to induce tolerance in type 1 diabetes, demonstrating its potential as a curative treatment. The therapy also shows promise for other autoimmune diseases, with results suggesting no impact on the immune system's ability to capture and process liposomes.
SourceGermans Trias i Pujol Research Institute·JournalJournal of Autoimmunity·TypeExperimental study·DateMar 18, 2024
The tumor microenvironment (TME) is a complex ecosystem surrounding tumors that impacts tumor development, metastasis, and responses to therapies. The review highlights potential therapeutic targets modulating TME components, including immune cells, stromal cells, and ECM proteins, to inhibit tumor progression.
SourceSichuan International Medical Exchange and Promotion Association·JournalMedComm – Oncology·DateMar 4, 2024
A new study from the University of British Columbia has found that sublingual immunotherapy (SLIT) is safe and effective for older children with multiple food allergies, who cannot risk consuming allergens orally. The treatment involves placing smaller amounts of food allergens under the tongue, allowing patients to build up their resi...
SourceUniversity of British Columbia·JournalJournal of Allergy and Clinical Immunology·TypeExperimental study·DateFeb 28, 2024
The American Academy of Otolaryngology has released a new clinical practice guideline supporting clinicians with evidence-based recommendations on immunotherapy for inhalant allergies. The guideline provides 12 key action statements to guide treatment, aiming to optimize patient care and reduce unnecessary variation in management.
SourceAmerican Academy of Otolaryngology - Head and Neck Surgery·JournalOtolaryngology·DateFeb 26, 2024
A recent study by Cold Spring Harbor Laboratory researchers reveals that chronic stress can increase cancer's ability to spread. By mimicking chronic stress in mice with cancer, the team discovered that stress causes neutrophils to form sticky web-like structures called NETs, making body tissues more susceptible to metastasis.
SourceCold Spring Harbor Laboratory·JournalCancer Cell·DateFeb 22, 2024
Apple AirPods Pro (2nd Generation, USB-C)
Apple AirPods Pro (2nd Generation, USB-C) provide clear calls and strong noise reduction for interviews, conferences, and noisy field environments.
Researchers have found a new potential therapeutic target for autoimmune diseases such as lupus and multiple sclerosis by identifying an overlooked sequence in the IκBζ protein. This sequence, known as the OCA peptide, can activate key proteins in immune cells and may help reeling in immune cells gone haywire.
SourceCold Spring Harbor Laboratory·JournalMolecular Cell·DateFeb 20, 2024
Researchers found that widely used machine learning tools produce biased results for immunotherapy research, as they rely heavily on datasets from higher-income communities. This can lead to ineffective treatments for lower-income populations. The study highlights the need for accurate and unbiased data in machine learning models.
SourceRice University·JournaliScience·TypeData/statistical analysis·DateFeb 16, 2024
A new clinical trial demonstrates a small reduction in the latent reservoir of HIV-infected cells using a combination of vorinostat and immunotherapy. While the results are promising, further research is needed to create more effective approaches to flush out the virus and attack it when it emerges from latency.
SourceUniversity of North Carolina Health Care·JournalThe Journal of Infectious Diseases·DateFeb 13, 2024
A new study has identified a genetic marker that can predict which patients are likely to respond to immunotherapy in various types of cancer. Tumors with high intragenic rearrangement (IGR) burden, which indicates cryptic structural rearrangements of the genetic code, may respond better to immunotherapy.
SourceUniversity of Pittsburgh·JournalCancer Immunology Research·DateFeb 13, 2024
Creality K1 Max 3D Printer
Creality K1 Max 3D Printer rapidly prototypes brackets, adapters, and fixtures for instruments and classroom demonstrations at large build volume.
Researchers discovered that VISTA induces immune suppressor cells called myeloid-derived suppressor cells (MDSCs) through a feedback loop involving STAT3 and polyamines. This pathway has high translational impact for several human cancers, offering promising drug targets.
SourceCleveland Clinic·JournalCell Reports·DateFeb 9, 2024
A systematic review found that female individuals and caregivers tend to report a greater impact of food allergy on health-related quality of life. Additionally, males may experience more improvements in quality of life following immunotherapy for food allergy.
SourceWiley·JournalClinical & Experimental Allergy·DateFeb 7, 2024
Researchers found that tumors with preexisting immune cell networks were most primed to respond to adoptive T cell therapy, and patients whose tumors featured such networks responded best to treatment. The study provides a step towards identifying patients who are likely to benefit from personalized immunotherapies.
SourceLudwig Institute for Cancer Research·JournalScience Immunology·DateFeb 6, 2024
Researchers have discovered that CAR T cells can be repurposed to target senescent cells, which accumulate with age and cause inflammation. This breakthrough offers a promising alternative to existing treatments, which often require repeated administration.
SourceCold Spring Harbor Laboratory·JournalNature Aging·DateJan 24, 2024
Meta Quest 3 512GB
Meta Quest 3 512GB enables immersive mission planning, terrain rehearsal, and interactive STEM demos with high-resolution mixed-reality experiences.
Senescent tumour cells generated by chemotherapy can create an environment that helps tumour cells escape treatment. Eliminating these cells with immunotherapy boosts the effectiveness of chemotherapy.
SourceInstitute for Research in Biomedicine (IRB Barcelona)·JournalNature Cancer·DateJan 24, 2024
Researchers have revealed CD4+ T cells can work effectively on their own to control melanoma, challenging conventional understanding. Harnessing their potential therapeutically holds great promise for improving current cancer immunotherapies.
SourceThe Peter Doherty Institute for Infection and Immunity·JournalScience Immunology·TypeExperimental study·DateJan 19, 2024
Researchers found that specific microbes in the gut reduce graft versus host disease after stem cell transplantation. Patients with low microbial metabolite risk index had better survival rates, fewer graft vs. host reactions, and reduced relapses.
SourceTechnical University of Munich (TUM)·JournalNature Cancer·TypeObservational study·DateJan 8, 2024
Researchers uncover a link between hyperactive Rac2 and human immune deficiency, shedding light on a mysterious condition. They also find promise in using cellular cannibalism to enhance cancer treatment.
SourceUniversity of California - Santa Barbara·JournalProceedings of the National Academy of Sciences·DateJan 5, 2024
DJI Air 3 (RC-N2)
DJI Air 3 (RC-N2) captures 4K mapping passes and environmental surveys with dual cameras, long flight time, and omnidirectional obstacle sensing.
A Stanford University study reveals that ENPP1 is produced by both cancer cells and healthy cells around tumors, with high levels linked to immunotherapy resistance and metastases. Researchers found that targeting ENPP1 could improve patient responses to existing medicines and help clinicians better predict patient outcomes
SourceStanford University·JournalProceedings of the National Academy of Sciences·DateDec 20, 2023
A phase 1 clinical trial demonstrates the efficacy of third-generation anti-CD19 CAR T-cells in treating relapsed or refractory B-cell non-Hodgkin lymphomas without causing neurotoxicity. The study also shows a robust response rate of 52% and improved safety profile compared to previous CAR T-cell therapies.
SourceMalaghan Institute of Medical Research·JournalBlood·TypeExperimental study·DateDec 11, 2023
A world-first human trial shows that a commonly prescribed rheumatoid arthritis drug can safely and effectively preserve the body's own insulin production and suppress the progression of type 1 diabetes. The drug, baricitinib, was found to be effective in maintaining insulin production in people who initiated treatment within 100 days ...
SourceSt Vincent's Institute of Medical Research·JournalNew England Journal of Medicine·TypeRandomized controlled/clinical trial·DateDec 6, 2023
Nikon Monarch 5 8x42 Binoculars
Nikon Monarch 5 8x42 Binoculars deliver bright, sharp views for wildlife surveys, eclipse chases, and quick star-field scans at dark sites.
Researchers discovered distinct mechanisms controlling different types of immune cells and found a way to selectively eliminate 'problematic' cells driving autoimmune disorders. This breakthrough offers precise targets for potential treatment strategies, potentially revolutionizing the way we treat skin conditions.
SourceThe Peter Doherty Institute for Infection and Immunity·JournalScience·TypeExperimental study·DateNov 30, 2023
Researchers are exploring new ways to fight metastasis, including the use of bacteria to activate a defensive response against cancer. Stress and changes in circadian rhythms have also been linked to metastasis, suggesting that these factors may be targets for prevention or treatment.
SourceCentro Nacional de Investigaciones Oncológicas (CNIO)·DateNov 14, 2023
Researchers have successfully used a specially formulated toothpaste for Oral Mucosal Immunotherapy (OMIT) to desensitize adults with peanut allergies. The study showed that 100% of participants consistently tolerated the highest dose without severe reactions, and 97% adhered to treatment.
SourceAmerican College of Allergy, Asthma, and Immunology·DateNov 9, 2023
CalDigit TS4 Thunderbolt 4 Dock
CalDigit TS4 Thunderbolt 4 Dock simplifies serious desks with 18 ports for high-speed storage, monitors, and instruments across Mac and PC setups.
Maintenance immunosuppressive drugs linked to increased COVID-19 hospitalization risk in solid organ transplant patients. Clinicians treating transplant recipients should consider these findings for epidemic-related decisions.
SourceJAMA Network·JournalJAMA Network Open·DateNov 7, 2023
Researchers found that beta-blockers can revive exhausted killer T cells, making them better cancer fighters. The study discovered a link between the sympathetic stress response and immune system response to cancer.
A team of Chinese and UK researchers has identified superoxide dismutase 1 (SOD1) as a potential target for reversing drug resistance in ovarian cancer. By using nanoparticles to deliver siRNA that reduces SOD1 levels, the study showed reduced growth and decreased resistance to cisplatin in female mice.
SourceXi'an Jiaotong-Liverpool University·JournalCancer Gene Therapy·TypeExperimental study·DateSep 6, 2023
A recent study found that ChatGPT scored 9/10 in accuracy for debunking Covid-19 vaccine myths, making it a reliable source of non-technical information. The AI tool's responses were accurate in addressing both true and false contraindications, but highlighted potential concerns over changes in answers over time.
SourceTaylor & Francis Group·JournalHuman Vaccines & Immunotherapeutics·TypeSurvey·DateSep 3, 2023
GQ GMC-500Plus Geiger Counter
GQ GMC-500Plus Geiger Counter logs beta, gamma, and X-ray levels for environmental monitoring, training labs, and safety demonstrations.
Researchers at Gladstone Institutes identified conditions that enable gamma delta T cells to recognize cancer cells by disrupting energy production and causing cellular stress. This insight suggests that therapies manipulating butyrophilin abundance on the surface of cancer cells could boost gamma delta T cell effectiveness.
A recent case study highlights the challenges faced by families seeking venom immunotherapy for fire ant allergies, particularly in low-income communities. Despite proven safety and effectiveness of treatment, access remains a significant issue due to transportation barriers, lack of childcare, and work constraints.
SourceOchsner Health System·JournalJournal of Allergy and Clinical Immunology·DateAug 23, 2023
A new study published in BMJ Oncology has found that relatively short-term use of immunosuppressant medications to control inflammatory diseases is not associated with an increased risk of developing cancer. The research included over 10,000 participants and tracked their cancer incidence for an average of 10 years.
SourceUniversity of Pittsburgh·JournalBMJ Oncology·TypeObservational study·DateAug 21, 2023
Researchers have developed an oncolytic virus that can 'warm up' cold tumors and improve immunotherapy outcomes. The virus was engineered to carry a gene encoding a TGF-β inhibitor, which greatly increased survival rates in mice with aggressive melanoma and other cancers.
SourceUniversity of Pittsburgh·JournalJournal of Experimental Medicine·TypeExperimental study·DateAug 14, 2023
Research suggests gut microbiota plays a crucial role in shaping immunotherapy response, with alterations contributing to cancer progression. The study aims to discuss the effect of microbiota on cancer immunotherapy and potential applications for improving treatment outcomes.
SourceFirst Hospital of Jilin University·JournaleGastroenterology·DateAug 10, 2023
Aranet4 Home CO2 Monitor
Aranet4 Home CO2 Monitor tracks ventilation quality in labs, classrooms, and conference rooms with long battery life and clear e-ink readouts.
Researchers found that ranolazine, a heart medication, slows down tumor progression and increases visibility of melanoma cells to the immune system. This combination could improve response rates for immunotherapies in patients with melanoma.
SourceInstitute for Research in Biomedicine (IRB Barcelona)·JournalNature Metabolism·TypeExperimental study·DateAug 10, 2023
Researchers discovered that STING, a critical immune regulator, can act as an ion channel to control immune responses. This new function allows STING to translate danger signals into ion flow, activating various defense mechanisms.
SourceMassachusetts Institute of Technology·JournalScience·DateAug 3, 2023
The IBS-KAI Conference will focus on viral diseases and immunology, featuring over 20 international experts. The conference aims to prepare for responses to future infectious diseases, including those with pandemic potentials.
Apple MacBook Pro 14-inch (M4 Pro)
Apple MacBook Pro 14-inch (M4 Pro) powers local ML workloads, large datasets, and multi-display analysis for field and lab teams.
A study published in Cancers found that a combination of radiotherapy followed by immunotherapy is effective against oral malignant melanomas in dogs. The treatment strategy increased overall survival time compared to immunotherapy alone. Researchers are now exploring the optimal protocol for this therapy to increase its effectiveness.
SourceHokkaido University·JournalCancers·TypeRandomized controlled/clinical trial·DateJun 22, 2023
Researchers discuss the potential of glucocorticoid-induced TNFR-related protein (GITR) as a target for cancer immunotherapy. Preclinical studies have shown potent anti-tumor efficacy, but clinical trials have yielded inconsistent results due to complexities in immune responses and antibody structure.
SourceImpact Journals LLC·JournalOncotarget·TypeCommentary/editorial·DateJun 21, 2023
Researchers have identified a key protein in the body's innate ability to fight systemic fungal infections. The study found that C5a and its downstream effects are crucial for immune cells to clear the fungus Candida albicans when it overtakes natural defenses.
SourceHackensack Meridian Health·JournalCell·TypeExperimental study·DateJun 15, 2023